DarioHealth Corp. Board Changes and Officer Compensation
Ticker: DRIO · Form: 8-K · Filed: Apr 5, 2024 · CIK: 1533998
| Field | Detail |
|---|---|
| Company | Dariohealth CORP. (DRIO) |
| Form Type | 8-K |
| Filed Date | Apr 5, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.0001, $350,000, m, $100,000 |
| Sentiment | neutral |
Sentiment: neutral
Topics: board-change, officer-compensation
TL;DR
DarioHealth board shakeup: Yaffa Bar-On joins, Yishai Klein exits. Officer pay details also filed.
AI Summary
DarioHealth Corp. announced on April 4, 2024, a change in its board of directors. Specifically, Ms. Yaffa Bar-On has been appointed as a new director, and Mr. Yishai Klein has resigned from the board. The company also disclosed compensatory arrangements for certain officers.
Why It Matters
Changes in board composition can signal shifts in company strategy or governance, while details on officer compensation are important for understanding executive incentives.
Risk Assessment
Risk Level: low — This filing primarily concerns routine board and officer changes, not significant financial events.
Key Players & Entities
- DarioHealth Corp. (company) — Registrant
- Yaffa Bar-On (person) — Newly appointed director
- Yishai Klein (person) — Resigned director
FAQ
Who has been appointed as a new director to the DarioHealth Corp. board?
Ms. Yaffa Bar-On has been appointed as a new director.
Who has resigned from the DarioHealth Corp. board of directors?
Mr. Yishai Klein has resigned from the board.
What is the exact date of the earliest event reported in this 8-K filing?
The date of the earliest event reported is April 4, 2024.
What is the principal executive office address for DarioHealth Corp.?
The address is 122 W 57th St, #33B, New York, New York 10019.
What other information is disclosed regarding officers in this filing?
The filing also discloses compensatory arrangements of certain officers.
Filing Stats: 481 words · 2 min read · ~2 pages · Grade level 12 · Accepted 2024-04-05 16:30:25
Key Financial Figures
- $0.0001 — registered Common Stock, par value $0.0001 per share DRIO The Nasdaq Capital M
- $350,000, m — Officer, Zvi Ben-David was increased to $350,000, maintained his target bonus of up to 40%
- $100,000 — potential one-time cash bonus of up to $100,000, subject to certain thresholds as to be
Filing Documents
- tm2411223d1_8k.htm (8-K) — 25KB
- tm2411223d1_ex10-1.htm (EX-10.1) — 14KB
- 0001104659-24-044299.txt ( ) — 212KB
- drio-20240404.xsd (EX-101.SCH) — 3KB
- drio-20240404_lab.xml (EX-101.LAB) — 33KB
- drio-20240404_pre.xml (EX-101.PRE) — 22KB
- tm2411223d1_8k_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Dated: April 5, 2024 DARIOHEALTH CORP. By: /s/ Zvi Ben David Name: Zvi Ben David Title: Chief Financial Officer, Treasurer and Secretary